» Articles » PMID: 35905186

ATP-competitive Inhibitors Modulate the Substrate Binding Cooperativity of a Kinase by Altering Its Conformational Entropy

Overview
Journal Sci Adv
Specialties Biology
Science
Date 2022 Jul 29
PMID 35905186
Authors
Affiliations
Soon will be listed here.
Abstract

ATP-competitive inhibitors are currently the largest class of clinically approved drugs for protein kinases. By targeting the ATP-binding pocket, these compounds block the catalytic activity, preventing substrate phosphorylation. A problem with these drugs, however, is that inhibited kinases may still recognize and bind downstream substrates, acting as scaffolds or binding hubs for signaling partners. Here, using protein kinase A as a model system, we show that chemically different ATP-competitive inhibitors modulate the substrate binding cooperativity by tuning the conformational entropy of the kinase and shifting the populations of its conformationally excited states. Since we found that binding cooperativity and conformational entropy of the enzyme are correlated, we propose a new paradigm for the discovery of ATP-competitive inhibitors, which is based on their ability to modulate the allosteric coupling between nucleotide and substrate-binding sites.

Citing Articles

Advances in pyrazolo[1,5-]pyrimidines: synthesis and their role as protein kinase inhibitors in cancer treatment.

Iorkula T, Jude-Kelly Osayawe O, Odogwu D, Ganiyu L, Faderin E, Awoyemi R RSC Adv. 2025; 15(5):3756-3828.

PMID: 39911541 PMC: 11795850. DOI: 10.1039/d4ra07556k.


Role of the αC-β4 loop in protein kinase structure and dynamics.

Wu J, Jonniya N, Hirakis S, Olivieri C, Veglia G, Kornev A Elife. 2024; 12.

PMID: 39630082 PMC: 11616992. DOI: 10.7554/eLife.91980.


Exploring the conformational landscape of protein kinases.

Gough N, Kalodimos C Curr Opin Struct Biol. 2024; 88:102890.

PMID: 39043011 PMC: 11694674. DOI: 10.1016/j.sbi.2024.102890.


The αC-β4 loop controls the allosteric cooperativity between nucleotide and substrate in the catalytic subunit of protein kinase A.

Olivieri C, Wang Y, Walker C, Veliparambil Subrahmanian M, Ha K, Bernlohr D Elife. 2024; 12.

PMID: 38913408 PMC: 11196109. DOI: 10.7554/eLife.91506.


CDK2 and CDK4: Cell Cycle Functions Evolve Distinct, Catalysis-Competent Conformations, Offering Drug Targets.

Zhang W, Liu Y, Jang H, Nussinov R JACS Au. 2024; 4(5):1911-1927.

PMID: 38818077 PMC: 11134382. DOI: 10.1021/jacsau.4c00138.


References
1.
Tzeng S, Kalodimos C . Dynamic activation of an allosteric regulatory protein. Nature. 2009; 462(7271):368-72. DOI: 10.1038/nature08560. View

2.
Foda Z, Shan Y, Kim E, Shaw D, Seeliger M . A dynamically coupled allosteric network underlies binding cooperativity in Src kinase. Nat Commun. 2015; 6:5939. PMC: 4300553. DOI: 10.1038/ncomms6939. View

3.
Lisi G, Manley G, Hendrickson H, Rivalta I, Batista V, Loria J . Dissecting Dynamic Allosteric Pathways Using Chemically Related Small-Molecule Activators. Structure. 2016; 24(7):1155-66. PMC: 4938718. DOI: 10.1016/j.str.2016.04.010. View

4.
Lisi G, Loria J . Solution NMR Spectroscopy for the Study of Enzyme Allostery. Chem Rev. 2016; 116(11):6323-69. PMC: 4937494. DOI: 10.1021/acs.chemrev.5b00541. View

5.
Kim J, Masterson L, Cembran A, Verardi R, Shi L, Gao J . Dysfunctional conformational dynamics of protein kinase A induced by a lethal mutant of phospholamban hinder phosphorylation. Proc Natl Acad Sci U S A. 2015; 112(12):3716-21. PMC: 4378435. DOI: 10.1073/pnas.1502299112. View